Osaic Holdings
ORIC icon

Osaic Holdings’s Oric Pharmaceuticals ORIC Stock Holding History

Osaic Holdings’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.61K Sell
610
-149
-20% -$1.35K ﹤0.01% 6807
2026
Q1 		$9.62K Buy
759
+76
+11% +$863 ﹤0.01% 6317
2025
Q4 		$5.59K Buy
683
+664
+3,495% +$7.64K ﹤0.01% 6649
2025
Q3 		$228 Sell
19
-1
-5% -$11 ﹤0.01% 7681
2025
Q2 		$203 Buy
+20
New +$134 ﹤0.01% 7500
2024
Q2 		– Sell
-281
Closed -$3.86K – 7559
2024
Q1 		$3.86K Buy
281
+31
+12% +$368 ﹤0.01% 6208
2023
Q4 		$2.3K Sell
250
-250
-50% -$1.81K ﹤0.01% 6493
2023
Q3 		$3.02K Buy
+500
New +$4.1K ﹤0.01% 6463
2022
Q2 		– Sell
-264
Closed -$1K – 7526
2022
Q1 		$1K Buy
+264
New +$2.38K ﹤0.01% 7091

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's ORIC Position: Q2 2026 in Review

Osaic Holdings reduced its Oric Pharmaceuticals (ORIC) stake by 20% in Q2 2026, selling an estimated $1.35K and leaving 610 shares worth $6.61K. The position accounts for ﹤0.01% of the portfolio, ranked #6807.

Osaic Holdings first reported a position in ORIC in Q1 2022 and has held it in 9 quarters since. The position peaked at $9.62K in Q1 2026. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Osaic Holdings held 610 shares of Oric Pharmaceuticals worth $6.61K as of Q2 2026.
  • Osaic Holdings sold 149 Oric Pharmaceuticals shares in Q2 2026, an estimated $1.35K.
  • Oric Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6807 holding.
  • Osaic Holdings first reported a position in Oric Pharmaceuticals in Q1 2022 and has held it in 9 quarters since.
  • Osaic Holdings's Oric Pharmaceuticals position peaked at $9.62K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.